Caravaca A S, Centa M, Gallina A L, Tarnawski L, Olofsson P S
1Laboratory of Immunobiology, Center for Bioelectronic Medicine, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
2Center for Biomedical Science and Bioelectronic Medicine, The Feinstein Institute for Medical Research, Manhasset, NY 11030 USA.
Bioelectron Med. 2020 Jan 31;6:3. doi: 10.1186/s42234-020-0038-7. eCollection 2020.
Atherosclerosis is a multifactorial chronic inflammatory disease that underlies myocardial infarction and stroke. Efficacious treatment for hyperlipidemia and hypertension has significantly reduced morbidity and mortality in cardiovascular disease. However, atherosclerosis still confers a considerable risk of adverse cardiovascular events. In the current mechanistic understanding of the pathogenesis of atherosclerosis, inflammation is pivotal both in disease development and progression. Recent clinical data provided support for this notion and treatment targeting inflammation is currently being explored. Interestingly, neural reflexes regulate cytokine production and inflammation. Hence, new technology utilizing implantable devices to deliver electrical impulses to activate neural circuits are currently being investigated in treatment of inflammation. Hopefully, it may become possible to target vascular inflammation in cardiovascular disease using bioelectronic medicine. In this review, we discuss neural control of inflammation and the potential implications of new therapeutic strategies to treat cardiovascular disease.
动脉粥样硬化是一种多因素慢性炎症性疾病,是心肌梗死和中风的基础。高脂血症和高血压的有效治疗显著降低了心血管疾病的发病率和死亡率。然而,动脉粥样硬化仍然带来相当大的心血管不良事件风险。在目前对动脉粥样硬化发病机制的机制理解中,炎症在疾病发展和进展中都起着关键作用。最近的临床数据支持了这一观点,目前正在探索针对炎症的治疗方法。有趣的是,神经反射调节细胞因子的产生和炎症。因此,目前正在研究利用植入式设备传递电脉冲以激活神经回路的新技术来治疗炎症。有望利用生物电子医学针对心血管疾病中的血管炎症。在这篇综述中,我们讨论炎症的神经控制以及治疗心血管疾病新治疗策略的潜在意义。